News for hackers. Stuff that matters.
Re:Antibiotic Breakthrough Ends 25-Year Discovery Drought by _craft on Wednesday January 07, 2015 @05:22PM (#8853725)
Thanks for the informative response! Do you know how expensive clinical trials would be for this kind of drug?
Re:Antibiotic Breakthrough Ends 25-Year Discovery Drought by skosuri on Wednesday January 07, 2015 @05:30PM (#8853770)
$100M-500M gets thrown around [1] but it's hard to find good data. This might seem not too high, but many drugs fail, and often fail at the most costly step (phase III). So you have to be sure to factor that failure rate in.

[1] http://www.manhattan-institute.org/html/fda_05.htm

Re:Antibiotic Breakthrough Ends 25-Year Discovery Drought by refurb on Wednesday January 07, 2015 @05:31PM (#8853773)
Depends on what indication they are trying to get. A handy estimate is that a phase III trial costs $15K/person/year. If they aim for a 1000 person trial of 6 month duration, you're looking at $15M just for the phase 3 (I doubled it since they typically run two). However, that's a small trial.
Re:Antibiotic Breakthrough Ends 25-Year Discovery Drought by Fomite on Thursday January 08, 2015 @01:57PM (#8858127)
Fidaxomycin, which was developed by Optimer Pharmaceuticals to treat C. difficle, was relatively inexpensive to run. I want to say in the vicinity of $100 million